Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-03-12 | 2022-04-21 | 108625 |
| ACT PIOGLITAZONE | 45MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-18 | 216454 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Actual shortage | 2017-11-16 | 2018-10-11 | 29438 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 4MG 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110703 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2017-08-24 | 2017-10-10 | 20315 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42635 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108012 |
| TEVA-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-05-14 | 109577 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110761 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Resolved | 2020-06-11 | 2023-10-03 | 117593 |
| TEVA-PHENIRAM | 4MG | TABLET | Resolved | 2020-09-11 | 2020-09-24 | 124119 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-09-24 | 2020-11-12 | 125007 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-11-27 | 2020-12-17 | 129050 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2021-04-08 | 2021-09-09 | 137203 |
| TEVA-ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |